Antibodies, Monoclonal, Humanized [CS] - M0556300
Pharmacologic Class Information
Pharmacologic Code | M0556300 |
Pharmacologic Name | Antibodies, Monoclonal, Humanized |
Pharmacologic Uses |
|
Pharmacologic Concept | Chemical Structure - [CS] |
Pharmacologic Concept Description | This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy. |
NDC Products with Antibodies, Monoclonal, Humanized
The table contains 5 products whose active ingredient are classified under the same pharmacologic class Antibodies, Monoclonal, Humanized [CS].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0597-0197 | Praxbind | Non-Proprietary Name: Idarucizumab | Injection | Intravenous | Boehringer Ingelheim Pharmaceuticals, Inc. | ACTIVE | |
50242-150 | Ocrevus | Non-Proprietary Name: Ocrelizumab | Injection | Intravenous | Genentech, Inc. | ACTIVE | |
50242-917 | Tecentriq | Non-Proprietary Name: Atezolizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | |
50242-918 | Tecentriq | Non-Proprietary Name: Atezolizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | |
62064-122 | Trogarzo | Non-Proprietary Name: Ibalizumab | Injection, Solution | Intravenous | Theratechnologies Inc. | ACTIVE |